142 related articles for article (PubMed ID: 32246324)
1. The effectiveness and safety of thromboprophylaxis in cancer patients based on Khorana score: a meta-analysis and systematic review of randomized controlled trials.
Bao Y; Gao B; Yan P; Tian L; Yang K
Clin Transl Oncol; 2020 Nov; 22(11):1992-2001. PubMed ID: 32246324
[TBL] [Abstract][Full Text] [Related]
2. Primary thromboprophylaxis in ambulatory cancer patients with a high Khorana score: a systematic review and meta-analysis.
Bosch FTM; Mulder FI; Kamphuisen PW; Middeldorp S; Bossuyt PM; Büller HR; van Es N
Blood Adv; 2020 Oct; 4(20):5215-5225. PubMed ID: 33104795
[TBL] [Abstract][Full Text] [Related]
3. Direct oral anticoagulants for thromboprophylaxis in ambulatory patients with cancer.
Wang Y; Wang M; Ni Y; Liang Z
Hematology; 2020 Dec; 25(1):63-70. PubMed ID: 31984870
[No Abstract] [Full Text] [Related]
4. Thromboprophylaxis for trauma patients.
Barrera LM; Perel P; Ker K; Cirocchi R; Farinella E; Morales Uribe CH
Cochrane Database Syst Rev; 2013 Mar; (3):CD008303. PubMed ID: 23543562
[TBL] [Abstract][Full Text] [Related]
5. Low-Molecular-Weight Heparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Arthroscopic Surgery and Anterior Cruciate Ligament Reconstruction: A Meta-analysis of Randomized Controlled Trials.
Zhu J; Jiang H; Marshall B; Li J; Tang X
Am J Sports Med; 2019 Jul; 47(8):1994-2002. PubMed ID: 30113231
[TBL] [Abstract][Full Text] [Related]
6. Apixaban versus enoxaparin for thromboprophylaxis after total hip or knee arthroplasty: a meta-analysis of randomized controlled trials.
Li XM; Sun SG; Zhang WD
Chin Med J (Engl); 2012 Jul; 125(13):2339-45. PubMed ID: 22882859
[TBL] [Abstract][Full Text] [Related]
7. Thromboprophylaxis for orthopedic surgery; An updated meta-analysis.
Haykal T; Adam S; Bala A; Zayed Y; Deliwala S; Kerbage J; Ponnapalli A; Malladi S; Samji V; Ortel TL
Thromb Res; 2021 Mar; 199():43-53. PubMed ID: 33422802
[TBL] [Abstract][Full Text] [Related]
8. D-Dimer Enhances Risk-Targeted Thromboprophylaxis in Ambulatory Patients with Cancer.
Kumar V; Shaw JR; Key NS; Ilich A; Mallick R; Wells PS; Carrier M
Oncologist; 2020 Dec; 25(12):1075-1083. PubMed ID: 32969580
[TBL] [Abstract][Full Text] [Related]
9. Low molecular weight heparin versus unfractionated heparin for perioperative thromboprophylaxis in patients with cancer.
Akl EA; Kahale L; Sperati F; Neumann I; Labedi N; Terrenato I; Barba M; Sempos EV; Muti P; Cook D; Schünemann H
Cochrane Database Syst Rev; 2014 Jun; (6):CD009447. PubMed ID: 24966161
[TBL] [Abstract][Full Text] [Related]
10. Systemic treatments for the prevention of venous thrombo-embolic events in paediatric cancer patients with tunnelled central venous catheters.
Schoot RA; Kremer LC; van de Wetering MD; van Ommen CH
Cochrane Database Syst Rev; 2013 Sep; (9):CD009160. PubMed ID: 24026801
[TBL] [Abstract][Full Text] [Related]
11. Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery.
Rasmussen MS; Jørgensen LN; Wille-Jørgensen P
Cochrane Database Syst Rev; 2009 Jan; (1):CD004318. PubMed ID: 19160234
[TBL] [Abstract][Full Text] [Related]
12. Parenteral anticoagulation in ambulatory patients with cancer.
Akl EA; Kahale LA; Ballout RA; Barba M; Yosuico VE; van Doormaal FF; Middeldorp S; Bryant A; Schünemann H
Cochrane Database Syst Rev; 2014 Dec; (12):CD006652. PubMed ID: 25491949
[TBL] [Abstract][Full Text] [Related]
13. Extended duration of thromboprophylaxis for medically ill patients: a systematic review and meta-analysis of randomised controlled trials.
Zayed Y; Kheiri B; Barbarawi M; Banifadel M; Abdalla A; Chahine A; Obeid M; Haykal T; Yelangi A; Malapati S; Bachuwa G; Seedahmed E
Intern Med J; 2020 Feb; 50(2):192-199. PubMed ID: 31276276
[TBL] [Abstract][Full Text] [Related]
14. Perioperative Pharmacological Thromboprophylaxis in Patients With Cancer: A Systematic Review and Meta-analysis.
Guo Q; Huang B; Zhao J; Ma Y; Yuan D; Yang Y; Du X
Ann Surg; 2017 Jun; 265(6):1087-1093. PubMed ID: 27849664
[TBL] [Abstract][Full Text] [Related]
15. Primary prophylaxis for venous thromboembolism in ambulatory cancer patients: a systematic review and network meta-analysis.
Xin Z; Liu F; Du Y; Mao F; Wang X; Xu P; Li Z; Qian J; Yao J
Ann Palliat Med; 2020 Sep; 9(5):2970-2981. PubMed ID: 32787358
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of primary thromboprophylaxis for the prevention of venous thromboembolism in patients with cancer and a central venous catheter: A systematic review and meta-analysis.
Li A; Brandt W; Brown C; Wang TF; Ikesaka R; Delluc A; Wells P; Carrier M
Thromb Res; 2021 Dec; 208():58-65. PubMed ID: 34715510
[TBL] [Abstract][Full Text] [Related]
17. Prophylaxis for venous thromboembolic disease in pregnancy and the early postnatal period.
Bain E; Wilson A; Tooher R; Gates S; Davis LJ; Middleton P
Cochrane Database Syst Rev; 2014 Feb; (2):CD001689. PubMed ID: 24519568
[TBL] [Abstract][Full Text] [Related]
18. The Khorana score for prediction of venous thromboembolism in cancer patients: An individual patient data meta-analysis.
van Es N; Ventresca M; Di Nisio M; Zhou Q; Noble S; Crowther M; Briel M; Garcia D; Lyman GH; Macbeth F; Griffiths G; Iorio A; Mbuagbaw L; Neumann I; Brozek J; Guyatt G; Streiff MB; Baldeh T; Florez ID; Gurunlu Alma O; Agnelli G; Ageno W; Marcucci M; Bozas G; Zulian G; Maraveyas A; Lebeau B; Lecumberri R; Sideras K; Loprinzi C; McBane R; Pelzer U; Riess H; Solh Z; Perry J; Kahale LA; Bossuyt PM; Klerk C; Büller HR; Akl EA; Schünemann HJ;
J Thromb Haemost; 2020 Aug; 18(8):1940-1951. PubMed ID: 32336010
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of thromboprophylaxis in cancer patients: a systematic review and meta-analysis.
Liu M; Wang G; Li Y; Wang H; Liu H; Guo N; Han C; Peng Y; Yang M; Liu Y; Ma X; Yu K; Wang C
Ther Adv Med Oncol; 2020; 12():1758835920907540. PubMed ID: 32215058
[TBL] [Abstract][Full Text] [Related]
20. Primary Thromboprophylaxis in Ambulatory Pancreatic Cancer Patients Receiving Chemotherapy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Frere C; Crichi B; Bournet B; Canivet C; Abdallah NA; Buscail L; Farge D
Cancers (Basel); 2020 Jul; 12(8):. PubMed ID: 32722064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
